GP-3.1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGP-3.1
Drug Alias Nameprotein HLA class II modulators (GenPat77)protein HLA class II modulators (GenPat77)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHistocompatibility antigens class II modulators
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenPat77 Pharmacogenetics AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenPat77 Pharmacogenetics AG
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A